The study was supported by grants from the French Ministry of Health and Celgene. The researchers reported having no financial disclosures.
SOURCE: Beylot-Barry M et al. J Invest Dermatol. 2018 Mar 26. doi: 10.1016/j.jid.2018.03.1516.
From the Journals
Lenalidomide yields responses in a rare cutaneous lymphoma
